BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death

  • Huey Jiun Ko
  • , Shean Jaw Chiou
  • , Cheng Yu Tsai
  • , Joon Khim Loh
  • , Xin Yi Lin
  • , Thu Ha Tran
  • , Chia Chung Hou
  • , Tai Shan Cheng
  • , Jin Mei Lai
  • , Peter Mu Hsin Chang
  • , Feng Sheng Wang
  • , Chun Li Su
  • , Chi Ying F. Huang*
  • , Yi Ren Hong*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Search results